ALS2 p.Val397Phe
c.1189G>T · VCV4089788
Computational evidence
| Protein change | ||
| AlphaMissense | 0.3076 | likely benign |
|---|---|---|
| REVEL | 0.153 | moderately benign-leaning |
| SaProt | LLR -7.83 | tolerated |
| ⇒ AlphaMissense, REVEL and SaProt all call this tolerated. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 4.8 | GERP 1.7, phastCons 1 |
| Regional constraint | o/e 0.88 | unconstrained · MANE · 11 kb · p 0.0064 · regional, not allelic |
| Overall | ||
| CADD | 23.0 | PHRED · no single calibrated threshold — expert panels disagree |
ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- ALS2
- Protein
- p.Val397Phe
- Coding
- c.1189G>T
- MANE Select
- NM_020919
- Type
- single nucleotide variant
- Location
- chr2:201757684 (GRCh38)
- Gene constraint
- LOEUF 0.649 · pLI <0.01 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
- Structure
- AlphaFold pLDDT 74.69
Similar variants
- ALS2 p.Arg1139Ter Pathogenic/Likely pathogenic ★★ same condition
- ALS2 p.Ala333Ser Uncertain significance ★★ ⚠ same condition
- ALS2 p.Ala377Thr Uncertain significance ★★ ⚠ same condition
- ALS2 p.Ala402Thr Uncertain significance ★★ ⚠ same condition
- ALS2 p.Arg1329Trp Uncertain significance ★★ ⚠ same condition
- ALS2 p.Arg1330His Uncertain significance ★★ ⚠ same condition
- ALS2 p.Arg1405Cys Uncertain significance ★★ ⚠ same condition
- ALS2 p.Arg1461Gln Uncertain significance ★★ ⚠ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/als2-p-val397phe (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown